Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F23822)

Formulation Name

Mirabegron 25mg extended release tablet

Company

Apgdi

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Mirabegron	DMS1GYT	Overactive bladder	GC50.0	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylated hydroxytoluene	E00336	31404	Antioxidant
Ferric hydroxide oxide yellow	E00539	23320441	Colorant
Haematite red	E00236	14833	Colorant
Hydroxypropyl cellulose	E00632	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose	E00634	Not Available	Coating agent
Magnesium stearate	E00208	11177	lubricant
Polyethylene glycol 4000	E00654	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant

--------------------